Analysis of fomepizole safety based on a 16-year post-marketing experience in France.
Saved in:
| Title: | Analysis of fomepizole safety based on a 16-year post-marketing experience in France. |
|---|---|
| Authors: | Rasamison R; AGEPS, Pharmaceutical Establishment of Paris Hospitals, APHP, Paris, France., Besson H; AGEPS, Pharmaceutical Establishment of Paris Hospitals, APHP, Paris, France., Berleur MP; AGEPS, Pharmaceutical Establishment of Paris Hospitals, APHP, Paris, France., Schicchi A; Department of Medical and Toxicological Critical Care, Federation of Toxicology APHP, Lariboisière Hospital, University of Paris, Paris, France.; Poison Control Centre and National Toxicology Information Centre - Toxicology Unit, Istituti Clinici Scientifici Maugeri, IRCCS Maugeri Hospital and University of Pavia, Pavia, Italy., Mégarbane B; Department of Medical and Toxicological Critical Care, Federation of Toxicology APHP, Lariboisière Hospital, University of Paris, Paris, France.; Inserm Umrs 1144, University of Paris, Paris, France. |
| Source: | Clinical toxicology (Philadelphia, Pa.) [Clin Toxicol (Phila)] 2020 Jul; Vol. 58 (7), pp. 742-747. Date of Electronic Publication: 2019 Oct 14. |
| Publication Type: | Journal Article |
| Journal Info: | Publisher: Informa Healthcare Country of Publication: England NLM ID: 101241654 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1556-9519 (Electronic) Linking ISSN: 15563650 NLM ISO Abbreviation: Clin Toxicol (Phila) Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
| ISSN: | 1556-9519 |
|---|---|
| DOI: | 10.1080/15563650.2019.1676899 |
